LATE DIAGNOSIS – IS IT A PROBLEM?

Slides:

Advertisements

Similar presentations

AHM 2011 Alyn Morice University of Hull HYMS COPD Disease not Disorder?

Advertisements

Public Health Perspective on Radon Control in Ireland Dr. Ina Kelly Specialist Registrar in Public Health Medicine Health Service Executive Department.

S A B D C T = 0 S gets message from above and sends messages to A, C and D S.

Factorial Designs. Background Factorial designs are when different treatments are evaluated within the same randomised trial. A factorial design has a.

Case Study MICR Hematology Spring, 2011 Case # Team members here Note: Embedded in your PowerPoint, you must address all questions in the case!

COPD Patients‘ Bill of Rights Jochen Scheld. The Bill of Rights.

Managing depression in people with long term conditions Chris Dickens Professor of Psychological Medicine Peninsula College of Medicine and Dentistry.

Eye care and public health: successes and challenges Department of Optometry & Visual Science Excellence in Eye Care Education and Research for over 100.

© 2013 Global Initiative for Chronic Obstructive Lung Disease

Clinical aspects of smoking cessation Jean-Pierre Zellweger, MD Swiss Lung Association and Int. Union against TB and Lung Disease (The Union)

Chronic Obstructive Pulmonary Disease

World Conference on COPD Patients

The National Lung Health Education Program Programs for the Respiratory Therapist.

Approach To Pneumonia. Pneumonia Importance Mechanism Classification & its benefit Diagnosis Treatment.

TOBACCO USE & OLDER SMOKERS. OLDER SMOKERS In 2004, 3.7 million people aged 65 and older were smokers and 16% of all people aged 50 and older smoked;

Session 3 - Workshop Brian Godman and Dr Alan Haycox Health Economics Unit University of Liverpool Management School Onco-Pharmacoeconomy Training Course.

Community based integrated intervention for prevention and management of Chronic Obstructive Pulmonary Disease in Guangdong, China: cluster randomised.

Presenting Organization Event Name Event Date Presenter Name, Title COPD Essentials for Physicians

A 1 Closing Remarks C. Elaine Jones, Ph.D Vice President Respiratory Regulatory Affairs.

Process of study selection F. Sofi, et al. BMJ 2008 Sep 11;337:a1344.

Chronic Obstructive Pulmonary Disease. COPD is an umbrella term for two diseases which cause progressive airflow obstruction Chronic Bronchitis- Inflammation.

J R Hurst Thorax : Depart. Of Pulmonology R3 백승숙.

Palliative Care: Emergency Room Interaction

The smoking epidemic and lung cancer in the EU

Rupert Jones Jill Pooler; Bruce Kirenga; Winceslas Katagira

Treating Mild COPD Dr Vincent Mak

Vascular Dementia Lewis and Escalin.

Why and How to Quit Smoking

Predicted 5-year benefits of LDL cholesterol reductions with statin treatment at different levels of risk. (A) Major vascular events, and (B) vascular.

Easily Missed Ectopic Pregnancy.

Jane E Scullion Respiratory Nurse Consultant

LUNG DISEASES © 2016 Paul Billiet ODWS.

Professor Colin P. Bradley University College Cork

The Relationship Between Mental and Physical Health

Overview The Burden of COPD Main Challenges in the Diagnosis of COPD.

EFA Book on COPD in Europe

Kaplan-Meier survival curves by frequency of exacerbations in patients with COPD: group A, patients with no acute exacerbations of COPD; group B, patients.

Modifying Disease Course in Alzheimer's Disease

Community Health Pearl:

Prevalence of statin and beta-blocker use by clinical presentation

Diabetes hazard rates by number of visits with reported statin use.

Mean expense per year on courses and conferences that trainees have not been reimbursed. Mean expense per year on courses and conferences that trainees.

SMILE Trial design: NSTEMI patients were randomized to complete revascularization during the index procedure (i.e., 1-stage revascularization; n = 264)

Early Referral for Patients With IBD Failing Conventional Therapies

Accelerated Partner Therapy (APT) index patient and sex partner flow diagram, clinics A and B. (1) Number of clinic attenders diagnosed with chlamydia,

FOURIER Trial design: Patients with established cardiovascular disease on statin therapy were randomized to evolocumab 140 mg subcutaneous every 2 weeks.

Capturing the learning from the field visit

Scatterplot showing the association between baseline weight and weight change at 1 year, relative to baseline for each treatment group. Scatterplot showing.

Self-management in chronic conditions: an integrated approach

Gestione clinica della BPCO

Nat. Rev. Neurol. doi: /nrneurol

Baseline Demographic Characteristics of Adults With Diagnosed Heart Failure and Eligible to Receive Lipid-Lowering Therapy Alan S. Go, et al.

Schematic overview of the suggested pharmacological management of chronic obstructive pulmonary disease (COPD). Schematic overview of the suggested pharmacological.

Changes in 6 min walk distance (6MWD) for combined pulmonary fibrosis and emphysema (CPFE) (n=15), and chronic obstructive pulmonary disease (COPD) (n=37).

A study of two UK hospitals found that 11% of admitted patients experienced adverse events of which 48% of these events were most likely preventable.

Morbidity and mortality benefits with statin use in observational studies on a logarithmic scale. Morbidity and mortality benefits with statin use in observational.

Benefit from Earlier Intervention

Screening test accuracy of the final risk score at a threshold of ≥2

What are the Causes of Type 2 diabetes? Anyway, an intervention aim relates to the standard of impact of the determinant.

Suggested algorithm of addressing non-motor symptoms in clinic (modified from Chaudhuri et al).48 HCP, healthcare professional; QoL, quality of life; PDSS,

The telesystem. The telesystem. Patients received regular automated calls from a computer-linked telesystem. Patients could also directly contact the telesystem.

Forest plot from meta-analysis carried out on four studies including high-dose N-acetylcysteine (NAC) treatment a) assessing the relative risk of chronic.

Prevalence of chronic obstructive pulmonary disease (COPD) defined by different criteria by region. The dark grey bar represents ‘symptom-based COPD’,

Distribution of NEWS in the community by service

Cox regression analysis of the proportion of patients remaining in remission during azathioprine treatment related to diagnosis of inflammatory bowel disease.

Kaplan-Meier survival curves by frequency of exacerbations in patients with COPD: group A, patients with no acute exacerbations of COPD; group B, patients.

Cox regression analysis of the proportion of patients remaining in remission after stopping azathioprine treatment related to diagnosis of inflammatory.

Odds ratio (95% confidence intervals) of reporting respiratory symptoms in patients with treated hypothyroidism or inflammatory bowel disease (IBD) compared.

Occurrence of falls and depressive symptoms on the basis of the set of risk factors (poor self rated health, poor cognitive status, impaired ADL, two or.

Change in COPD (chronic obstructive pulmonary disease) assessment test (CAT) score after pulmonary rehabilitation corresponding to different responses.

Presentation transcript:

LATE DIAGNOSIS – IS IT A PROBLEM? Professor Peter Calverley University Hospital Aintree Liverpool UK

Is former Cardinal Ratzinger a member of the Church of Rome? Of course it is but why?

OPPORTUNITY COSTS OF LATE DIAGNOSIS Continued exposure to risk factors –lost chances for smoking cessation (Parkes et al BMJ 2008) Lost opportunities to benefit from effective therapy that can modify the natural history of disease Delayed use of rehabilitation Problems of mis-attributed symptoms –what is wrong with me? Inappropriate treatment Increased risk of COPD-related depression? Limited chances to change function for the better IT SENDS THE WRONG MESSAGES ABOUT COPD